These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 24852093)

  • 1. Perspective and potential of oral lipid-based delivery to optimize pharmacological therapies against cardiovascular diseases.
    Rao S; Tan A; Thomas N; Prestidge CA
    J Control Release; 2014 Nov; 193():174-87. PubMed ID: 24852093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges in Oral Drug Delivery and Applications of Lipid Nanoparticles as Potent Oral Drug Carriers for Managing Cardiovascular Risk Factors.
    Okur NÜ; Siafaka PI; Gökçe EH
    Curr Pharm Biotechnol; 2021; 22(7):892-905. PubMed ID: 32753006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid-based systems as a promising approach for enhancing the bioavailability of poorly water-soluble drugs.
    Cerpnjak K; Zvonar A; Gašperlin M; Vrečer F
    Acta Pharm; 2013 Dec; 63(4):427-45. PubMed ID: 24451070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective in-vivo utilization of lipid-based nanoparticles as drug carrier for carvedilol phosphate.
    Chakraborty S; Shukla D; Vuddanda PR; Mishra B; Singh S
    J Pharm Pharmacol; 2011 Jun; 63(6):774-9. PubMed ID: 21585374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solid lipid nanoparticles: an oral bioavailability enhancer vehicle.
    Harde H; Das M; Jain S
    Expert Opin Drug Deliv; 2011 Nov; 8(11):1407-24. PubMed ID: 21831007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in lipid nanodispersions for parenteral drug delivery and targeting.
    Constantinides PP; Chaubal MV; Shorr R
    Adv Drug Deliv Rev; 2008 Mar; 60(6):757-67. PubMed ID: 18096269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assembling nanoparticle coatings to improve the drug delivery performance of lipid based colloids.
    Simovic S; Barnes TJ; Tan A; Prestidge CA
    Nanoscale; 2012 Feb; 4(4):1220-30. PubMed ID: 22159191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physical chemical considerations of lipid-based oral drug delivery--solid lipid nanoparticles.
    Bummer PM
    Crit Rev Ther Drug Carrier Syst; 2004; 21(1):1-20. PubMed ID: 15099183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.
    Dahan A; Hoffman A
    J Control Release; 2008 Jul; 129(1):1-10. PubMed ID: 18499294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral nanomedicine approaches for the treatment of psychiatric illnesses.
    Dening TJ; Rao S; Thomas N; Prestidge CA
    J Control Release; 2016 Feb; 223():137-156. PubMed ID: 26739547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Nanostructured Solid Materials for Modulating Oral Drug Delivery from Solid-State Lipid-Based Drug Delivery Systems.
    Dening TJ; Rao S; Thomas N; Prestidge CA
    AAPS J; 2016 Jan; 18(1):23-40. PubMed ID: 26354801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term stability, biocompatibility and oral delivery potential of risperidone-loaded solid lipid nanoparticles.
    Silva AC; Kumar A; Wild W; Ferreira D; Santos D; Forbes B
    Int J Pharm; 2012 Oct; 436(1-2):798-805. PubMed ID: 22867992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of topotecan loaded lipid nanoparticles for chemical stabilization and prolonged release.
    Souza LG; Silva EJ; Martins AL; Mota MF; Braga RC; Lima EM; Valadares MC; Taveira SF; Marreto RN
    Eur J Pharm Biopharm; 2011 Sep; 79(1):189-96. PubMed ID: 21352915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second generation lipid nanoparticles (NLC) as an oral drug carrier for delivery of lercanidipine hydrochloride.
    Ranpise NS; Korabu SS; Ghodake VN
    Colloids Surf B Biointerfaces; 2014 Apr; 116():81-7. PubMed ID: 24445002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An in vitro digestion test that reflects rat intestinal conditions to probe the importance of formulation digestion vs first pass metabolism in Danazol bioavailability from lipid based formulations.
    Anby MU; Nguyen TH; Yeap YY; Feeney OM; Williams HD; Benameur H; Pouton CW; Porter CJ
    Mol Pharm; 2014 Nov; 11(11):4069-83. PubMed ID: 25265395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing intestinal drug solubilisation using lipid-based delivery systems.
    Porter CJ; Pouton CW; Cuine JF; Charman WN
    Adv Drug Deliv Rev; 2008 Mar; 60(6):673-91. PubMed ID: 18155801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in topical ophthalmic drug delivery with lipid-based nanocarriers.
    Gan L; Wang J; Jiang M; Bartlett H; Ouyang D; Eperjesi F; Liu J; Gan Y
    Drug Discov Today; 2013 Mar; 18(5-6):290-7. PubMed ID: 23092895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioadhesion and enhanced bioavailability by wheat germ agglutinin-grafted lipid nanoparticles for oral delivery of poorly water-soluble drug bufalin.
    Liu Y; Wang P; Sun C; Zhao J; Du Y; Shi F; Feng N
    Int J Pharm; 2011 Oct; 419(1-2):260-5. PubMed ID: 21816211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymer-lipid hybrid systems: merging the benefits of polymeric and lipid-based nanocarriers to improve oral drug delivery.
    Rao S; Prestidge CA
    Expert Opin Drug Deliv; 2016; 13(5):691-707. PubMed ID: 26866382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid nanoparticles: effect on bioavailability and pharmacokinetic changes.
    Souto EB; Müller RH
    Handb Exp Pharmacol; 2010; (197):115-41. PubMed ID: 20217528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.